Windtree Therapeutics Files Patent Application in India for Istaroxime, Advancing Arrhythmia Treatment
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has filed a national phase patent application with the Indian patent office for its innovative heart failure treatment, Istaroxime. The application, entitled “ISTAROXIME …
Windtree Therapeutics Files Patent Application in India for Istaroxime, Advancing Arrhythmia Treatment Read More